Cyclin D1 in astrocytic tumours: an immunohistochemical study
A Chakrabarty1, L R Bridges, S Gray
1Neuropathology Laboratory, General Infirmary at Leeds, University of Leeds, UK.
Neuropathology and Applied Neurobiology
|August 1, 1996
Summary
Cyclin D1 is overexpressed in astrocytic tumors, increasing with malignancy grade. Its expression correlates with MIB1 (Ki-67) proliferation marker, especially in lower-grade tumors.
Area of Science:
- Neuro-oncology
- Cell biology
- Immunohistochemistry
Background:
- Astrocytic tumors are a significant group of primary brain tumors.
- Understanding cell cycle regulation is crucial for tumor grading and prognosis.
- Cyclin D1 and MIB1 (Ki-67) are key markers for cell cycle and proliferation.
Purpose of the Study:
- To investigate the expression of cyclin D1 and MIB1 (Ki-67) in astrocytic tumors.
- To correlate these markers with tumor grade and each other.
- To assess the diagnostic utility of cyclin D1 in astrocytic tumor classification.
Main Methods:
- Immunohistochemical staining of 48 astrocytic tumors using antibodies for cyclin D1 and MIB1 (Ki-67).
- Microwave antigen retrieval system utilized for formalin-fixed paraffin-embedded tissues.
- Tumor classification based on the 1993 WHO system.
Main Results:
- Mean labeling indices for both cyclin D1 and MIB1 increased with tumor malignancy grade.
- Significant differences in labeling indices were observed between low-grade (pilocytic, diffuse) and high-grade (anaplastic, glioblastoma) astrocytomas.
- Strong positive correlation between cyclin D1 and MIB1 was found in diffuse astrocytomas, but this correlation decreased in higher-grade tumors.
Conclusions:
- Cyclin D1 is overexpressed in astrocytic tumors, with expression levels rising with increasing malignancy.
- Cyclin D1 expression generally correlates with MIB1 (Ki-67) proliferation, suggesting its role in the proliferative cell pool.
- Cyclin D1 may serve as a valuable marker in the assessment of astrocytic tumor progression.
